Inno Biologics is a globally operating Contract Manufacturer for monoclonal antibodies and therapeutic proteins with state-of-the-art cGMP Manufacturing Facility. Our multiproduct mammalian cell culture facility has been designed in compliance with both EMEA and US FDA guidelines.
The single train cGMP facility houses 200L and 1,000L production bioreactors, associated inoculums suite and primary recovery equipment for efficient cell removal and concentration.
Following initial cell removal and product concentration, purification is performed in pre and post viral purification suites. We are proud to offer highly flexible purification systems to allow a wide variety of chromatographic techniques to be applied.
Our exceptional combination of upstream and downstream processing areas and technologies have been designed to provide maximum flexibility and capacity to meet the needs of clients requiring biomanufacturing services in all phases of clinical trials all according to the Good Manufacturing Practices (GMPs) guidelines.
Our extensive range of equipment includes: